# Editorial: repurposed linaclotide and the quest for abdominal pain management in irritable bowel syndrome.

> PubMed lists PMID 36565004 in Alimentary pharmacology & therapeutics as Editorial, Comment, with publication-date metadata of 2023-01 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-36565004-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2023-02-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-36565004-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-36565004-linaclotide-v1.json
- Content SHA-256: `e7925d320c0bb249e2a705b8c076f7196e81684889720d27325cca2d5adc5e84`

## Claims and source pins

### Headline

Editorial: repurposed linaclotide and the quest for abdominal pain management in irritable bowel syndrome. ([`pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d`](#source-pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d))

### Summary

PubMed lists PMID 36565004 in Alimentary pharmacology & therapeutics as Editorial, Comment, with publication-date metadata of 2023-01 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d`](#source-pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d))

### Paragraph 1

PubMed lists PMID 36565004 in Alimentary pharmacology & therapeutics as Editorial, Comment, with publication-date metadata of 2023-01 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d`](#source-pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d`](#source-pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d))

## Sources

<a id="source-pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d"></a>
- **Editorial: repurposed linaclotide and the quest for abdominal pain management in irritable bowel syndrome. · retained source version 1:2023-02-26:current:d432cc74866dc520e09ffc1f10685e17cc6399b5a5fe3aab3284c91a636d8662** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/36565004/) (`pubmed-observation-pmid-36565004-2023-02-26-d432cc74866d`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Editorial: repurposed linaclotide and the quest for abdominal pain management in irritable bowel syndrome." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-36565004-linaclotide-v1.json SHA-256: e7925d320c0bb249e2a705b8c076f7196e81684889720d27325cca2d5adc5e84.